Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
8.10M | 8.18M | 11.36M | 23.70M | 26.48M | 32.88M | Gross Profit |
2.77M | 2.66M | 4.24M | 6.29M | 7.17M | 8.77M | EBIT |
-1.87M | 0.00 | -1.47M | -7.06M | -3.48M | -5.20M | EBITDA |
-780.00K | -1.05M | -334.00K | -1.43M | -2.32M | -5.20M | Net Income Common Stockholders |
-2.05M | -2.40M | -6.51M | -6.93M | -4.13M | -4.44M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.99M | 4.76M | 4.17M | 6.20M | 11.79M | 14.71M | Total Assets |
12.24M | 13.15M | 16.03M | 25.85M | 30.64M | 40.66M | Total Debt |
1.95M | 1.57M | 1.38M | 2.43M | 1.78M | 2.31M | Net Debt |
-2.03M | -3.19M | -2.79M | -3.77M | -10.01M | -12.40M | Total Liabilities |
3.61M | 3.73M | 4.47M | 8.22M | 7.65M | 12.31M | Stockholders Equity |
8.63M | 9.42M | 11.56M | 17.63M | 22.99M | 28.35M |
Cash Flow | Free Cash Flow | ||||
155.00K | 1.17M | -2.56M | -4.96M | -24.00K | -4.94M | Operating Cash Flow |
203.00K | 1.39M | -2.51M | -2.26M | 2.04M | -4.13M | Investing Cash Flow |
70.00K | -116.00K | 1.36M | -2.52M | -1.82M | -491.00K | Financing Cash Flow |
-276.00K | -692.00K | -900.00K | -939.00K | -2.93M | 678.00K |
EnWave Corporation reported its first quarter financial results for 2025, highlighting a mixed performance. The company saw a 14% increase in royalty revenues, driven by more royalty partners and product sales, but overall revenue decreased by 7% due to fewer machine sales. Despite this, the gross margin improved significantly to 29% from 18% in the previous year, attributed to higher royalties and tolling fees. The company also reported a reduced adjusted EBITDA loss, indicating an improvement in operational efficiency. The financial results reflect EnWave’s strategic focus on enhancing its royalty and tolling revenue streams, despite challenges in machine sales.
EnWave Corporation has entered an Equipment Purchase Agreement and License Amendment with Sprouted Proteins SAC in Peru, enhancing their collaboration. The amendment allows Sprouted Proteins exclusive rights to produce starch-based snacks and instant soups in Peru, with royalty payments to EnWave. Sprouted Proteins has also acquired REV™ machines to boost production, with plans to purchase a larger machine to maintain exclusive rights, strengthening EnWave’s market position.
EnWave Corporation has amended its royalty-bearing license agreement with Patatas Fritas Torres S.L. of Spain, allowing the latter to expand its product portfolio. By utilizing the existing distribution network, PFT aims to broaden its offerings in the nutritious, shelf-stable snack market, committing to pay additional annual royalties to EnWave. This expansion is expected to increase manufacturing utilization and could lead to further purchases of EnWave’s REV™ machinery, potentially boosting EnWave’s market position and stakeholder value.
EnWave Corporation will release its first-quarter financial results for the period ending December 31, 2024, on February 24, 2025. The company will host a conference call to discuss these results and its business outlook, led by CEO Brent Charleton and CFO Dylan Murray. This announcement is part of EnWave’s strategy to expand its market reach and reinforce its position in the dehydration technology sector, potentially benefiting its stakeholders by highlighting financial performance and future plans.
EnWave Corporation has amended its licensing agreement with BranchOut Foods Inc., granting exclusive rights to produce dried blueberry products using its REV™ technology in Peru, with an annual royalty requirement. This strategic move enhances EnWave’s market presence in Peru and strengthens BranchOut’s product portfolio, potentially increasing profitability and market competitiveness for both companies.
EnWave Corporation has entered into a Technology Evaluation and License Option Agreement with Solve Solutions, a Brazilian food company focused on premium dried products. This agreement allows Solve Solutions to evaluate EnWave’s Radiant Energy Vacuum (REV™) drying technology with the option to license it for producing select dried products in Brazil. This partnership marks EnWave’s expansion into the Brazilian market, potentially enhancing Solve Solutions’ capability to supply premium ingredients to underserved food manufacturers and brands, and signifies a strategic step in EnWave’s market positioning.
EnWave Corp has appointed Ms. Louise Lalonde to its Board of Directors as the new Audit Committee Chair, following the retirement of Ms. Mary Ritchie. Ms. Lalonde brings over 30 years of experience in accounting and governance, while EnWave continues its innovation in vacuum microwave dehydration technology for various industries.
EnWave Corporation has reported impressive financial results for the fourth quarter of 2024, with a significant revenue increase driven by the resale of a large-scale machine and higher royalties. The company also saw a substantial rise in net income from continuing operations, reflecting improved financial performance.